SE8705068L - Kristallina salter av /3s(z)/-2-///1-(2-amino-4-tiazolyl)-2-//2,2-dimetyl-4-oxo-1-(sulfooxi)-3-azetidinyl/-amino/-2-oxoetyliden/-amino/oxi/ettiksyra - Google Patents

Kristallina salter av /3s(z)/-2-///1-(2-amino-4-tiazolyl)-2-//2,2-dimetyl-4-oxo-1-(sulfooxi)-3-azetidinyl/-amino/-2-oxoetyliden/-amino/oxi/ettiksyra

Info

Publication number
SE8705068L
SE8705068L SE8705068A SE8705068A SE8705068L SE 8705068 L SE8705068 L SE 8705068L SE 8705068 A SE8705068 A SE 8705068A SE 8705068 A SE8705068 A SE 8705068A SE 8705068 L SE8705068 L SE 8705068L
Authority
SE
Sweden
Prior art keywords
amino
azetidinyl
thiazolyl
oxo
dimethyl
Prior art date
Application number
SE8705068A
Other languages
English (en)
Other versions
SE8705068D0 (sv
SE467782B (sv
Inventor
W L Parker
E M Cohen
W H Koster
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE8705068D0 publication Critical patent/SE8705068D0/sv
Publication of SE8705068L publication Critical patent/SE8705068L/sv
Publication of SE467782B publication Critical patent/SE467782B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8705068A 1986-12-19 1987-12-18 Dierytromycin- och dikolinsalterna av /3s(z)/-2///1-(2-amino-4-tiazolyl)-2-//2,2-dimetyl-4-oxo-1-(sulfoxi)-3-azetidinyl/amino/-2-oxoetyliden/amino/oxi/-aettiksyra anvaendbara vid behandling av bakterieinfektioner i daeggdjur samt foerfarande foer framstaellning daerav SE467782B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/944,283 US4751220A (en) 1986-12-19 1986-12-19 Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid

Publications (3)

Publication Number Publication Date
SE8705068D0 SE8705068D0 (sv) 1987-12-18
SE8705068L true SE8705068L (sv) 1988-06-20
SE467782B SE467782B (sv) 1992-09-14

Family

ID=25481130

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8705068A SE467782B (sv) 1986-12-19 1987-12-18 Dierytromycin- och dikolinsalterna av /3s(z)/-2///1-(2-amino-4-tiazolyl)-2-//2,2-dimetyl-4-oxo-1-(sulfoxi)-3-azetidinyl/amino/-2-oxoetyliden/amino/oxi/-aettiksyra anvaendbara vid behandling av bakterieinfektioner i daeggdjur samt foerfarande foer framstaellning daerav

Country Status (25)

Country Link
US (1) US4751220A (sv)
JP (1) JP2511083B2 (sv)
KR (1) KR960007534B1 (sv)
AU (1) AU600536B2 (sv)
BE (1) BE1000625A3 (sv)
CA (1) CA1296717C (sv)
CH (1) CH674009A5 (sv)
DE (1) DE3743111C2 (sv)
DK (1) DK671487A (sv)
ES (1) ES2007766A6 (sv)
FI (1) FI91757C (sv)
FR (1) FR2610627B1 (sv)
GB (1) GB2199033B (sv)
GR (1) GR871937B (sv)
HU (1) HU197568B (sv)
IE (1) IE61325B1 (sv)
IL (1) IL84521A (sv)
IT (1) IT1233457B (sv)
LU (1) LU87076A1 (sv)
NL (1) NL193639C (sv)
NZ (1) NZ222599A (sv)
PH (1) PH23170A (sv)
PT (1) PT86403B (sv)
SE (1) SE467782B (sv)
ZA (1) ZA879031B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US7087418B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
CN101724000B (zh) * 2008-10-29 2012-05-30 广东东阳光药业有限公司 一种红霉素的结晶方法
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN113975396B (zh) * 2021-11-09 2022-11-29 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES376380A1 (es) * 1970-01-30 1972-04-16 Roger Lab Procedimiento de obtencion de un nuevo derivado de eritro- micina.
AU8364875A (en) * 1974-08-21 1977-02-10 Hoffmann La Roche Choline and n-methyl-d-glucamine salts of amoxycillin
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4638061A (en) * 1985-01-28 1987-01-20 E. R. Squibb & Sons, Inc. [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Also Published As

Publication number Publication date
FI875159A0 (sv) 1987-11-23
AU600536B2 (en) 1990-08-16
BE1000625A3 (fr) 1989-02-21
DE3743111C2 (de) 1996-04-04
AU8185787A (en) 1988-06-23
IE873447L (en) 1988-06-19
ZA879031B (sv) 1988-05-27
JP2511083B2 (ja) 1996-06-26
IL84521A0 (en) 1988-04-29
NL8703047A (nl) 1988-07-18
FI91757C (sv) 1994-08-10
GB8727048D0 (en) 1987-12-23
FR2610627A1 (fr) 1988-08-12
PH23170A (en) 1989-05-19
SE8705068D0 (sv) 1987-12-18
CA1296717C (en) 1992-03-03
HU197568B (en) 1989-04-28
FI91757B (sv) 1994-04-29
JPS63165381A (ja) 1988-07-08
HUT45998A (en) 1988-09-28
DK671487A (da) 1988-06-20
NL193639B (nl) 2000-01-03
PT86403A (en) 1988-01-01
DE3743111A1 (de) 1988-06-30
US4751220A (en) 1988-06-14
DK671487D0 (da) 1987-12-18
SE467782B (sv) 1992-09-14
IT8722908A0 (it) 1987-12-07
IT1233457B (it) 1992-04-02
GR871937B (en) 1988-04-26
IE61325B1 (en) 1994-11-02
ES2007766A6 (es) 1989-07-01
KR880007528A (ko) 1988-08-27
CH674009A5 (sv) 1990-04-30
FI875159A (sv) 1988-06-20
NL193639C (nl) 2000-05-04
GB2199033B (en) 1990-10-24
GB2199033A (en) 1988-06-29
PT86403B (pt) 1990-11-20
FR2610627B1 (fr) 1989-12-01
IL84521A (en) 1992-02-16
KR960007534B1 (ko) 1996-06-05
LU87076A1 (fr) 1988-07-14
NZ222599A (en) 1989-09-27

Similar Documents

Publication Publication Date Title
ATE175965T1 (de) Amorphe form von aztreonam
AU7194991A (en) Macrolide pharmaceutical solutions
SE8705068D0 (sv) Kristallina salter av /3s(z)/-2-///1-(2-amino-4-tiazolyl)-2-//2,2-dimetyl-4-oxo-1-(sulfooxi)-3-azetidinyl/-amino/-2-oxoetyliden/-amino/oxi/ettiksyra
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
NO871575D0 (no) Fremgangsmaate for fremstilling av 1,5-benztiazepinderivater.
NO174258C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, krystallinske cefemsyreaddisjonssalter
EP0313945A3 (de) Mittel zur Behandlung des Bluthochdrucks und der Herzinsuffizienz
EP0453574A4 (en) Cephalosporin derivative
NO170014C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre
SE8804037L (sv) Nya 4-demetoxiantracyclinderivat
EP0080592B1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
IE870122L (en) Treatment of coronary disease
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.
ES2032203T3 (es) Procedimiento de preparacion de derivados del 5-(2-1-pirrolidinil)p-cimeno.
FI863895A0 (fi) Nya kristallmodifikationer av 3-metoxi-4-(4'-aminobenzensulfonamido)-1,2,5-tiadiazoler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8705068-8

Format of ref document f/p: F

NUG Patent has lapsed